SLC2A12 and breast cancer: The results demonstrated that IFNG, GABARAPL1, FH, BRD4, TFAP2C, MT1G, WIPI1, FADS2, SLC2A12 and NRAS mRNA levels were downregulated in BC specimens, especially in TNBC specimens.